Bicycle Therapeutics (BCYC) Assets Average (2019 - 2026)

Bicycle Therapeutics (BCYC) has 8 years of Assets Average data on file, last reported at $685.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 25.57% year-over-year to $685.0 million; the trailing twelve-month figure through Mar 2026 stood at $685.0 million (down 25.57% YoY), and the FY2025 full-year result was $837.2 million, up 7.88% from the prior year.
• Assets Average for Q1 2026 stood at $685.0 million, down from $740.8 million in the prior quarter.
• Across five years, Assets Average topped out at $1.0 billion in Q3 2024 and bottomed at $413.9 million in Q4 2022.
• The 5-year median for Assets Average is $617.0 million (2023), against an average of $657.2 million.
• The widest annual swing landed in 2022, when Assets Average jumped 143.99%; it then fell 25.57% in 2026.
• A 5-year view of Assets Average shows it stood at $413.9 million in 2022, then surged by 49.08% to $617.0 million in 2023, then surged by 58.31% to $976.8 million in 2024, then decreased by 24.16% to $740.8 million in 2025, then fell by 7.53% to $685.0 million in 2026.
• The last three Assets Average figures came in at $685.0 million (Q1 2026), $740.8 million (Q4 2025), and $798.1 million (Q3 2025), per Business Quant data.

Peer Comparison